Concepedia

Arunachalam Sekar

AS

8

Publications

249

Citations

8

H-Index

2017

Active since

Affiliations

Weizmann Institute of Science(Current)

Osaka University of Pharmaceutical Sciences

The University of Osaka

University of Cambridge

University of Bologna

Arunachalam Sekar is an author at Weizmann Institute of Science specializing in cell biology, medicine, and lung cancer.

ORCID

Top concepts

Publications per year

2017–2023

8

Publications

8

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee et al. · Cancer Discovery · 2022 · 94 citations · Full text

PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR

Soma Ghosh, Nishanth Belugali Nataraj, Ashish Noronha et al. · Cell Reports · 2021 · 44 citations · Full text

, , +10

ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma

Swati Srivastava, Nishanth Belugali Nataraj, Arunachalam Sekar et al. · Cell Reports · 2019 · 27 citations · Full text

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors

Nishanth Belugali Nataraj, Ashish Noronha, Joo Sang Lee et al. · Cell Reports · 2022 · 25 citations · Full text

TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis

Mary Luz Uribe, Maik Dahlhoff, R.N. Batra et al. · Science Signaling · 2021 · 17 citations · Full text

Rows per page

1–5 of 8